Could Generic Insulin Soon Hit the U.S. Market?sstrumello
Diabetes blogger Scott Strumello (sstrumello.blogspot.com) investigates whether follow-on (generic) insulin formulation will soon emerge in accordance with U.S. patent law.
Publish Date: January 1, 2007
In order to promote the uptake of biosimilars across the U.S., stakeholders must be informed about the basic science of these important medicines. Created out of the Biosimilars Forum's Biosimilars Roundtable (formerly the Biosimilars Forum Stakeholder Workshop group), this two page document incorporates feedback from nearly 40 stakeholder groups, from patient advocacy organizations to physician and payer groups, and presents the basic knowledge that all stakeholders need to know about the safety and efficacy of biosimilars, including answers to common myths about them.
CDC Webinar: Foodborne illness Outbreaks and Law with Attorney Bill MarlerBill Marler
Attorney and food safety expert William Marler give a May 2012, Centers for Disease Control and Prevention webinar on foodborne illness litigation and the role of public health officials.
Viscosity reduction by three feed enzymes was measured in a high throughput pressure sensing system using commercial dosages on purified polysaccharides (arabinoxylan and ß-glucan). Fluorescence and antibody microscopy techniques were also used to visualize effects on the solubilisation of endosperm cell walls of wheat and barley.
Viscosity data clearly demonstrated depolymerisation of mixed-linked ß-glucans by the two multicomponent enzymes. The two multicomponent enzymes also reduced the viscosity of the arabinoxylan solution, while the monocomponent xylanase most effectively depolymerised the arabinoxylan. Microscopy data revealed that the multicomponent enzyme chosen for the studies could solubilize barley cell walls by targeting both the ß-glucan strutures as well as the arabinoxylans. The xylanase could effectively solubilise barley cell walls by merely attacking the arabinoxylans.
Could Generic Insulin Soon Hit the U.S. Market?sstrumello
Diabetes blogger Scott Strumello (sstrumello.blogspot.com) investigates whether follow-on (generic) insulin formulation will soon emerge in accordance with U.S. patent law.
Publish Date: January 1, 2007
In order to promote the uptake of biosimilars across the U.S., stakeholders must be informed about the basic science of these important medicines. Created out of the Biosimilars Forum's Biosimilars Roundtable (formerly the Biosimilars Forum Stakeholder Workshop group), this two page document incorporates feedback from nearly 40 stakeholder groups, from patient advocacy organizations to physician and payer groups, and presents the basic knowledge that all stakeholders need to know about the safety and efficacy of biosimilars, including answers to common myths about them.
CDC Webinar: Foodborne illness Outbreaks and Law with Attorney Bill MarlerBill Marler
Attorney and food safety expert William Marler give a May 2012, Centers for Disease Control and Prevention webinar on foodborne illness litigation and the role of public health officials.
Viscosity reduction by three feed enzymes was measured in a high throughput pressure sensing system using commercial dosages on purified polysaccharides (arabinoxylan and ß-glucan). Fluorescence and antibody microscopy techniques were also used to visualize effects on the solubilisation of endosperm cell walls of wheat and barley.
Viscosity data clearly demonstrated depolymerisation of mixed-linked ß-glucans by the two multicomponent enzymes. The two multicomponent enzymes also reduced the viscosity of the arabinoxylan solution, while the monocomponent xylanase most effectively depolymerised the arabinoxylan. Microscopy data revealed that the multicomponent enzyme chosen for the studies could solubilize barley cell walls by targeting both the ß-glucan strutures as well as the arabinoxylans. The xylanase could effectively solubilise barley cell walls by merely attacking the arabinoxylans.
Social Media and Machine Learning in FoodBorne IllnessRaed Mansour
Raed Mansour presenting at the Illinois Institute of Technology Computer Science Seminar on the use of Machine Learning in Social Media as used by the Chicago Department of Public Health's FoodBorne Chicago app.
Listeria monocytogenes: An emerging foodborne pathogen in Ghana? ILRI
Presentation by K. Tano-Debrah, F.K. Saalia, B. Bediako-Amoa, J. Appiah, E. Dogbe and K. Bomfeh at the University of Ghana's College of Health Sciences annual scientific conference on the increasing burden of non-communicable diseases in Ghana held at Accra, Ghana on 21-23 September 2011.
Enzyme inhibition is explained with its kinetics, animations showing mechanism of inhibitors action, examples of inhibitors are explained in detail with Enzyme inhibited.
by Dr. N. Sivaranjani, MD
2011 Food Defense Summit: Legal Risks and Responsibilities for Producing Safe...Bill Marler
Bill Marler of Marler Clark, The Food Safety Law Firm gives a presentation at the 2011 Food Defense Summit in Denver about the legal aspects of food safety in food production and reducing foodborne illness.
Social Media and Machine Learning in FoodBorne IllnessRaed Mansour
Raed Mansour presenting at the Illinois Institute of Technology Computer Science Seminar on the use of Machine Learning in Social Media as used by the Chicago Department of Public Health's FoodBorne Chicago app.
Listeria monocytogenes: An emerging foodborne pathogen in Ghana? ILRI
Presentation by K. Tano-Debrah, F.K. Saalia, B. Bediako-Amoa, J. Appiah, E. Dogbe and K. Bomfeh at the University of Ghana's College of Health Sciences annual scientific conference on the increasing burden of non-communicable diseases in Ghana held at Accra, Ghana on 21-23 September 2011.
Enzyme inhibition is explained with its kinetics, animations showing mechanism of inhibitors action, examples of inhibitors are explained in detail with Enzyme inhibited.
by Dr. N. Sivaranjani, MD
2011 Food Defense Summit: Legal Risks and Responsibilities for Producing Safe...Bill Marler
Bill Marler of Marler Clark, The Food Safety Law Firm gives a presentation at the 2011 Food Defense Summit in Denver about the legal aspects of food safety in food production and reducing foodborne illness.
2011 NCASM Conference: Separating the Wheat from the Chaff with Bill MarlerBill Marler
Marler Clark Managing Partner Bill Marler's presentation to the Northern California American Society for Microbiology about the process of food safety plaintiff litigation
Print Share
Food Safety
Overview Objectives Interventions & Resources National Snapshots
View HP2020 Data for:
Food Safety
Midcourse Review Data
Are In!
Check out our interactive
infographic to see progress
toward the Food Safety objectives
and other Healthy People topic
areas.
Related Topic Areas
Environmental Health
Home » 2020 Topics & Objectives » Food Safety
Goal
Reduce foodborne illnesses in the United States by improving food safety-related behaviors and
practices.
Overview
Foodborne illnesses are a burden on public health and contribute significantly to the cost of health
care. Each year foodborne illnesses sicken 48 million Americans (approximately 17% of people in
the United States) and lead to 128,000 hospitalizations and 3,000 deaths. A small percentage of
these illnesses are the result of identified foodborne outbreaks, which happen when two or more
cases of similar illnesses result from eating the same food. Investigations of foodborne outbreaks,
along with analyses of data on the germs that make us sick and behaviors that contribute to food
contamination, help us identify where we can make improvements in the country’s food safety
system. This system spans from growing the food on the farm through processing, packing,
distribution, transportation, and storage, to preparing it to be eaten.
Why Is Food Safety Important?
Foodborne illnesses are a preventable and underreported public health problem. These illnesses
are a burden on public health and contribute significantly to the cost of health care. They also
present a major challenge to certain groups of people. Although anyone can get a foodborne illness,
some people are at greater risk. For example:
Children younger than age 4 have the highest incidence of laboratory-confirmed infections from some foodborne pathogens,
including Campylobacter, Cryptosporidium, Salmonella, Shiga toxin-producing Escherichia coli O157, Shigella, and Yersinia.
People older than age 50 and those with reduced immunity are at greater risk for hospitalizations and death from intestinal pathogens
commonly transmitted through foods.
Safer food promises healthier and longer lives and less costly health care, as well as a more resilient food industry.
Back to Top
Understanding Food Safety
Physical Determinants of Food Safety
Food hazards, including germs and chemical contaminants, can enter the food supply at any
point from farm to table. Most of these hazards cannot be detected in food when it is
purchased or consumed. In addition, a food itself can cause severe adverse reactions in people who are allergic to it. In the United States,
food allergies are a significant concern, both among children under age 18 and some adults.
Search HealthyPeople.gov
Go
1
2
3
4
4
5,6
Topics & Objectives Leading Health Indicators Data Search Healthy People in Action Tools & Resources Webinars & Events About
Log in
Learn More
FoodSafety.g.
The Impact of Global Commerce on Food Safety and Liability in 2009 with Bill ...Bill Marler
Marler Clark's Bill Marler speaks on the impact of global commerce on food safety and liability to the Canadian Institute of Public Health Inspectors in 2009
Welcome to the December Edition of Crisis Management’s RecallRegister, Aon’s monthly recall
and product safety newsletter. This publication provides a review of the month’s recalls as
reported by the U.S. Consumer Product Safety Commission (CPSC), the U.S Food and Drug
Administration (FDA), the U.S. Department of Agriculture (USDA), National Highway Traffic
Safety Administration (NHTSA) and the Canadian Food Inspection Agency (CFIA). In addition
to recall announcements, RecallRegister provides an update on the product recall and
contamination insurance marketplace and environment. Each month, we highlight issues of
importance including new markets and capacity, significant recall events and changes in
legislation affecting the consumer products industry.
Acute hemolytic uremic syndrome (HUS).
Post-diarrheal hemolytic uremic syndrome (D+HUS) is a severe, life-threatening complication that occurs in about 10 percent of those infected with E. coli O157:H7 or other Shiga toxin-producing (Stx) E. coli (STEC).
The cascade of events leading to HUS begins with ingestion of Stx-producing E. coli (e.g., E. coli O157: H7) in contaminated food, beverages, animal to person, or person-to-person transmission. The bacteria rapidly multiply in the gut, causing inflammation and diarrhea (colitis) as they tightly bind to cells that line the large intestine. This snug attachment becomes a route for the toxin to travel from the gut into the bloodstream, where it attaches to weak receptors on white blood cells (WBCs). From there, WBCs carry the toxin to the kidneys and other organs.
To induce toxicity in target cells, Shiga toxins must first bind to specific receptors on their surface (Gb3 receptors). Organ injury is primarily a function of Gb3 receptor location and density. They are found on epithelial, endothelial, mesangial, and glomerular cells of the kidney, as well as microvascular endothelial cells of the brain and intestine. Because this attachment causes these organs to be susceptible to the toxicity of Shiga toxins, this distribution explains the involvement of the gut, kidney, and brain in STEC-associated hemolytic uremic syndrome (HUS).
Within the target organ, Shiga toxins disrupt the cellular machinery, resulting in cell injury and/or death. Within the intestine, infectious bacterial lesions cause derangements in the intestinal lining, disrupting the structure of the villi, affecting absorption in the gut, and eventually leading to watery diarrhea. Damage to the intestinal endothelium also causes mucosal/submucosal edema and, hemorrhage, introducing blood into the diarrhea.
Within the circulatory system, Shiga toxins are directly involved in platelet activation and aggregation (clot formation). The thrombotic microangiopathy that characterizes hemolytic uremic syndrome (HUS) occurs when platelet microthrombi (tiny clots) form in the walls of small blood vessels (arterioles and capillaries) causing platelet consumption. This pathologic reduction in platelets is called thrombocytopenia and is one of the hallmarks of HUS. Within the microvasculature of the kidney these clots disturb blood flow to the organ, causing acute kidney injury and kidney failure.
Hemolytic Uremic Syndrome (HUS) chris edits 7.31.23.pptxBill Marler
Acute hemolytic uremic syndrome (HUS).
Post-diarrheal hemolytic uremic syndrome (D+HUS) is a severe, life-threatening complication that occurs in about 10 percent of those infected with E. coli O157:H7 or other Shiga toxin-producing (Stx) E. coli (STEC).
The cascade of events leading to HUS begins with ingestion of Stx-producing E. coli (e.g., E. coli O157: H7) in contaminated food, beverages, animal to person, or person-to-person transmission. The bacteria rapidly multiply in the gut, causing inflammation and diarrhea (colitis) as they tightly bind to cells that line the large intestine. This snug attachment becomes a route for the toxin to travel from the gut into the bloodstream, where it attaches to weak receptors on white blood cells (WBCs). From there, WBCs carry the toxin to the kidneys and other organs.
To induce toxicity in target cells, Shiga toxins must first bind to specific receptors on their surface (Gb3 receptors). Organ injury is primarily a function of Gb3 receptor location and density. They are found on epithelial, endothelial, mesangial, and glomerular cells of the kidney, as well as microvascular endothelial cells of the brain and intestine. Because this attachment causes these organs to be susceptible to the toxicity of Shiga toxins, this distribution explains the involvement of the gut, kidney, and brain in STEC-associated hemolytic uremic syndrome (HUS).
Within the target organ, Shiga toxins disrupt the cellular machinery, resulting in cell injury and/or death. Within the intestine, infectious bacterial lesions cause derangements in the intestinal lining, disrupting the structure of the villi, affecting absorption in the gut, and eventually leading to watery diarrhea. Damage to the intestinal endothelium also causes mucosal/submucosal edema and, hemorrhage, introducing blood into the diarrhea.
Within the circulatory system, Shiga toxins are directly involved in platelet activation and aggregation (clot formation). The thrombotic microangiopathy that characterizes hemolytic uremic syndrome (HUS) occurs when platelet microthrombi (tiny clots) form in the walls of small blood vessels (arterioles and capillaries) causing platelet consumption. This pathologic reduction in platelets is called thrombocytopenia and is one of the hallmarks of HUS. Within the microvasculature of the kidney these clots disturb blood flow to the organ, causing acute kidney injury and kidney failure.
31 of the Biggest Recalls in Food Safety HistoryBill Marler
In November 2018 Cheyenne Buckingham and John Harrington wrote “31 Food Recalls That Poisoned the Most People.” Here is the Marler Clark view of the same list.
I will be giving a talk on the 2011 Listeria Outbreak in the US that sickened 147 and killed at least 33. Over 100 have died from Listeria in South Africa in the last year.
2018 Royal Society for Public Health SpeechBill Marler
Later this month I will be giving a talk to the Royal Society for Public Health. The talk will be a bit of history of E. coli and the Jack in the Box case.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
2011 Rocky Mountain Food Safety Conference
1. 2011 Rocky Mountain Food Safety Conference Recent and Emerging Trends in Foodborne Illness Litigation Patti Waller Marler Clark May 17, 2011 Boulder, CO
4. 3,000 deathScallan E, Hoekstra RM, Angulo FJ, et. al. Foodborne illness acquired in the United States – major pathogens. EmergInfect Dis. 2011 Jan; http://www.cdc.gov/EID/content/17/1/7.htm
5. Foodborne Illness is Expensive $152 billion annual costs For five foodborne pathogens,* medical costs, productivity losses, and costs of premature death total: $6.9 BILLION * Campylobacter, Salmonella (non-typhoidal), E. coli O157:H7, Listeria monocytogenes, and other Shiga-toxin producing strains of E. coli. This represents only a fraction of the total costs due to foodborne illness, which include some costs, such as pain and suffering, that are difficult to quantify, and other costs, such as costs of recalls, lost sales, loss of reputation, and public health expenditures, that are often overlooked.
6. More than just a stomach ache According to the Food and Drug Administration, an estimated 2 to 3 percent of foodborne illness victims develop secondary long-term medical complications. That’s 1 million lingering health problems each year. See Frezen. Economic Research Service, USDA. The Economics of Food, Farming, National Resources & Rural America, www.ers.usda.gov
17. Likely to progress to end stage renal disease, requiring multiple kidney transplantsKatelyn after E. coli Since this horrific event occurred, people always ask me how our lives have changed and I don’t even know where to begin. Instead of getting into details, the answer I usually give is that “Everything has changed. Nothing is the same.” Katelyn’s mom
34. A few of the basics Plaintiff attorneys Defense attorneys Recovery of legitimate losses such as medical expenses and wages Coverage for future needs due to injury INSURANCE
35.
36. Strict Liability A manufacturer is liable if: The product had a defect which rendered it unreasonably dangerous; The defect existed at the time the product left the manufacturer’s control; and The defect caused injury
37. Who is a Manufacturer? The definition differs slightly in every state; A “manufacturer” is defined as a “product seller who designs, produces, makes, fabricates, constructs, or remanufacturers the relevant product or component part of a product before its sale to a user or consumer…” RCW 7.72.01 0(2); SEE ALSO Washburn v. Beatt Equipment Co., 120 Wn.2d 246 (1992)
38. Are restaurants manufacturers? Yes. For example, a foodservice operation that thawed, cooked, and seasoned ground beef for sale as school lunch tacos was held to be a manufacturer.The court ruled that there was no question that the defendant’s “cooking process falls neatly into the definition for “product,” “make,” “fabricate,” and “construct.” See Almquist v. Finley School District No. 53, 114 Wn. App. 395 (2002).
39. Why Strict Liability? It puts pressure on the party (manufacturers) that most likely could correct the problem in the first place. It puts the cost of settlements and verdicts directly on the party (manufacturers) that profited from the defective product’s sale.
40. NEGLIGENCE and non-manufacturers The reason for excluding non-manufacturing retailers from strict liability is to distinguish between those who have actual control over the product and those who act as mere conduitsin the chain of distribution. See Butello v. S.A. Woods-Yates Am. Mach. Co., 72 Wn.App. 397, 404 (1993).
44. BankruptcyDepending on laws in each state, these factors may put upstream suppliers and/or distributors at risk for liability.
45. Outbreaks of S. Baildon and S. Hartford Salmonella serotype Hartford 75 ill in 15 states Illness onsets between April 30 and July 18, 2010 Salmonella serotype Baildon 80 ill in 15 states Illness onsets between May 11 and July 19, 2010 Epidemiologic evidence points toward PRODUCE consumed at multiple Taco Bell restaurants
46. Peanut Corporation of America 2008-2009 Over 700 ill persons Over 150 people hospitalized 9 deaths 4000+ products recalled $12m has been applied to claims Bankruptcy FDA inspectors reported after spending 2 weeks at the Blakely, Georgia plant that the company knew its product was tainted with Salmonellabut shipped them anyway after re-testing. This happened at least 12 times in 2007-2008.
67. EPIDEMIOLOGY still rules! WRIGHT COUNTY EGGS INC From May 1 to November 30, 2010, approximately 1,939 illnesses of Salmonella Enteritidis infections occurred nationwide.
68. “New” Pathogens & Contaminated Foods “New” pathogens Non-O157 STECS Salmonella in meat MRSA and other antibiotic resistant bacteria “New” routes of exposure Intact vs. non-intact beef “New” vehicles of transmission Commercial Cookie Dough Nuts and nut products Celery and other vegetables/fruits
69.
70. Require larger food processors and manufacturers to register with the FDA and create detailed food safety plans;
84. Died on Wednesday+ for Salmonella Typhimurium PFGE match to PCA outbreak strain Pete never spoke to me again. He was hooked up to a breathing machine. He had needles stuck in him, it seemed like there was 15 to 20 needles total. I told him I loved him. I asked him if he loved me and with a pitiful look, he shook his head yes. It broke my heart to see him in this condition.
86. Questions, Comments? Patti Waller Marler Clark 1301 Second Avenue, Suite 2800 Seattle, WA 91801 pwaller@marlerclark.com www.marlerclark.com www.foodsafetynews.com www.outbreakdatabase.com